RGD‐modified anti‐CD3 antibodies redirect cytolytic capacity of cytotoxic T lymphocytes toward α<sub>v</sub>β<sub>3</sub>‐expressing endothelial cells
Astrid J. Schraa(University of Groningen), Grietje Molema(University Medical Center Groningen), Sebo Withoff(University Medical Center Groningen), Robbert J. Kok(Utrecht University), Sander M. Botter(Erasmus MC), Dirk K. F. Meijer(University of Groningen), Lou F. M. H. de Leij(University Medical Center Groningen)
Cited by 17
Related Papers
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
|Drug Resistance Updates|2005|461
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
|Advanced Drug Delivery Reviews|2013|396
Restricted diet delays accelerated ageing and genomic stress in DNA-repair-deficient mice
|Nature|2016|319
Diverse origins of the myofibroblast—implications for kidney fibrosis
|Nature Reviews Nephrology|2015|305